Code 81418 describes a test to evaluate a blood or saliva specimen for changes in at least six genes that may impact metabolism of many therapeutic drugs. The test must include CYP2C19 and CYP2D6 variant analysis and CYP2D6 duplication/deletion analysis. Clinicians may use the test to help determine appropriate dosage for medications.
For clinical responsibility, terminology, tips and additional info
start codify free trial.